DoW Peer Reviewed Cancer, Idea Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- May 6, 2026
- Amount
- Program total $18M
- Closes
- Oct 5, 2026 (in 17 days)
Similar opportunities open now
- DoW, Peer Reviewed Cancer, Impact AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 17 days
- DoW Peer Reviewed Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 17 days
- DoW Peer Reviewed Medical, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 4 days
- DoW Peer Reviewed Medical, Platform Clinical Translation AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 4 days
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 13 days
Classification and identifiers
- Solicitation number
- HT942526PRCRPIA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $18M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to Service Members, Veterans, other military beneficiaries and the American public. Distinctive Features: The proposed project should demonstrate creative thinking and innovation. • Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award. • Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale...